drugset / Trial / NCT06478459

Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer

NCT06478459 ↗

Phase 0 Unknown 20 enrolled Zhejiang University
NaSingle-groupOpen-labelTreatment

Summary

This is a single-center, single-arm, open-label, dose-escalation clinical study to evaluate the safety and anti-tumor efficacy of intratumoral NKG2D CAR-NK cell injection guided by endoscopic ultrasound in the treatment of locally advanced pancreatic cancer.

Timeline

Start
2024-06-09
Primary completion
2025-06-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject CAR-NK Cell therapy — Other